The Retina Research Group includes members of basic science laboratories conducting research in all aspects of retina and clinical physician-scientists involved in management, treatment and clinical research of various retinal diseases. The RRG meets quarterly on the first Tuesday of the month to discuss research and clinical activities of individual groups, followed by a business meeting to cover funding and collaborative opportunities and group management. The RRG is dedicated to multidisciplinary approaches involving the areas of cellular and molecular biology, genetics, epidemiology and clinical trials, as well as structural analysis, pathology, and physiology.
The mission of the group is to foster a greater understanding of the development, structure and function of the normal and diseased retina for the purpose of preserving and improving vision.
The principle vision of the RRG is to provide state of the art research programs and play a leadership role in the field nationally and internationally through excellence in our research programs to advance the understanding of retinal function and disease as well as to provide treatments and cures of retinal diseases.
Membership and Departmental Affiliation
Faculty and staff from several department and schools across the UW campus are members of the RRG, and include the department of Ophthalmology and Visual Sciences (DOVS), Genetics and Pediatrics in the UW School of Medicine and Public Health.
Cellular and animal models of retinal degenerations
Drug Delivery systems
High-resolution imaging of cells and tissues using confocal microscopy and electron microscopy
Non-invasive retinal imaging technologies
Biochemistry and molecular biology
Areas of Expected/Desired Growth
The future mission for the retina research group is to maintain the highest level of excellence in developing and delivering treatments for retinal diseases. Potential areas of expansion include cell biology, genetics, molecular biology, physiology, clinical trials, imaging, epidemiology and nutrition.